Overexpression and activation of the EGFR family can be seen in many human cancers and they are closely related to the clinicopathological characteristics and prognosis of many tumors, such as breast cancer [9], lung cancer [10], gastric cancer [11] and melanoma [12]. Here, EGFR is linked to breast carcinoma.